Brimonidine tartrate is a salt form of brimonidine, a quinoxaline derivative and alpha-2 adrenergic receptor agonist. It is a pharmaceutical raw material used in the manufacturing of ophthalmic preparations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 79570-19-7
Brimonidine
pharmaceutical raw material
Brimonidine D-tartrate
pharmaceutical raw material
Maytansinoid DM3
pharmaceutical raw material
Ravtansine
pharmaceutical raw material
Sertraline
pharmaceutical raw material
(1S-CIS)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPHTHALENAMINE 2-HYDROXY-2-PHENYLACETATE
pharmaceutical raw material
N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
pharmaceutical raw material
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
QZHBYNSSDLTCRG-LREBCSMRSA-N
C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O